Health Condition 1: H36- Retinal disorders in diseases classified elsewhere
Conditions
Interventions
Intervention1: effect of Phacoemulsification using a physiological IOP(20mmHg) and a high IOP (55 mmHg): Cataract Surgery on the Centurion Vision System with Active Fluidics and Active Sentry handpie
Sponsors
Alcon Laboratories USA
Eligibility
Inclusion criteria
Inclusion criteria: Age-related cataract with coexisting diabetic retinopathy (mild, moderate nonproliferative diabetic retinopathy with or without diabetic retinopathy)
Exclusion criteria
Exclusion criteria: Proliferative diabetic retinopathy with tractional disease or proliferative vitreoretinopathy Prior ocular trauma or surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| For Posterior Pole (macula) perfusion: Retinal vessel density & Perfusion density at superficial retinal layers at the posterior pole detected by OCTA at the following time points: within 2 hours of surgery, 1 day & 1 month postoperativelyTimepoint: 1) 1 day postoperatively - To capture OCT angiography, anterior chamber inflammation 2) 1 week postoperativelyTo document anterior chamber inflammation 3) 1 month postoperativelyTo document OCT angiography | — |
Secondary
| Measure | Time frame |
|---|---|
| For Optic nerve head perfusion: Perfusion & Flux index at the RPC layer detected by OCTA at the following time points: within 2 hours of surgery, 1 day & 1 month postoperatively Cumulative Dissipated Energy Fluid Used Patient comfort during surgery (VAS scale) Anterior chamber inflammation: measured on the slitlamp on postoperative day 1 & week 1 Timepoint: None | — |
Countries
India
Contacts
Public ContactDr Abhay R Vasavada
Raghudeep Eye Hospital
Outcome results
None listed